VIDEO: Minimal residual disease tests may ‘better match’ patients with care in AML
Noah Merin, MD, PhD
Disclosures
Merin reports he will be a speaker for Servier.
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
We're learning more about AML.
Breakthrough offers new hope for patients with relapsed blood cancer
Harbinger Health Presents Clinical Data at ASCO Supporting RESOLVE™ as a New Blood-Based Category for Evaluation of Suspected Cancer
Foundation Medicine Launches FoundationOne®MRD, First-of-Its-Kind Molecular Residual Disease Test to Combine Structural Variants and Digital PCR
A standing ovation for RevMed, and caution for Akeso
Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026
Discussing Emerging Therapies and Shared Decision-Making in Multiple Myeloma
Study: AI may help identify cancer survivors at risk for emergency visits, worsening symptoms
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session
Pharmalittle: We're reading about pancreatic and lung cancer drugs, China biotech growth, and more
Researchers From NYU Langone Health's Perlmutter Cancer Center Present Latest Findings at 2026 ASCO Annual Meeting
VIDEO: AML therapy regimens offer flexibility to fit patient needs
VIDEO: Triple therapy regimens being explored for acute myeloid leukemia
VIDEO: CAR-T in the frontline setting, other promising areas of research in myeloma
In this video, Adriana Rossi, MD, assistant professor of medicine at Mount Sinai, highlights upcoming clinical trials in multiple…
VIDEO: Immunotherapies offer new opportunities in relapsed, refractory myeloma
In this video, Adriana Rossi, MD, assistant professor of medicine at Mount Sinai, discusses future research directions in…
